These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 22956151)
1. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China. Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151 [TBL] [Abstract][Full Text] [Related]
2. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol. Schiavotto C; Castaman G; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755 [TBL] [Abstract][Full Text] [Related]
4. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808 [TBL] [Abstract][Full Text] [Related]
5. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262 [TBL] [Abstract][Full Text] [Related]
6. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases. Schiavotto C; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study. Michel M; Rauzy OB; Thoraval FR; Languille L; Khellaf M; Bierling P; Godeau B Am J Hematol; 2011 Dec; 86(12):980-4. PubMed ID: 21956157 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
10. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia. Zhou F; Xu Y; Zhang Z; Wu X; Jin R J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Bizzoni L; Mazzucconi MG; Gentile M; Santoro C; Bernasconi S; Chiarotti F; Foà R; Mandelli F Eur J Haematol; 2006 Mar; 76(3):210-6. PubMed ID: 16412138 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center. Daou S; Federici L; Zimmer J; Maloisel F; Serraj K; Andrès E Eur J Intern Med; 2008 Oct; 19(6):447-51. PubMed ID: 18848179 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Vianelli N; Valdrè L; Fiacchini M; de Vivo A; Gugliotta L; Catani L; Lemoli RM; Poli M; Tura S Haematologica; 2001 May; 86(5):504-9. PubMed ID: 11410414 [TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J; Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322 [TBL] [Abstract][Full Text] [Related]
19. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients. Aleem A Platelets; 2011; 22(1):1-7. PubMed ID: 20964585 [TBL] [Abstract][Full Text] [Related]
20. Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China. Wang T; Xu M; Ji L; Yang R Acta Haematol; 2006; 115(1-2):39-45. PubMed ID: 16424648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]